Navigation Links
'Project Runway' Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design

PHILADELPHIA, Oct. 18 /PRNewswire/ -- Jack Mackenroth, from the hit reality television series "Project Runway," is visiting Philadelphia for this year's annual AIDS Walk Philly and is bringing Living Positive By Design, a national HIV and AIDS education initiative, to the city. On Sunday, October 18th, Jack will participate in and speak at the Walk, which benefits 30 HIV organizations throughout the Delaware Valley Region through the AIDS Fund. The Living Positive By Design campaign seeks to help combat the stigma associated with HIV by engaging people in thoughtful conversation about the disease and is supported by Merck & Co., Inc.

"Merck's ongoing commitment to the HIV community is demonstrated through Living Positive By Design, which highlights the importance for people living with HIV to have a positive outlook on life while effectively managing their disease," said Mackenroth, who has been living with HIV for more than 20 years. "Philadelphia has been greatly impacted by HIV and I am proud to be partnering with Merck to bring awareness about the disease to their hometown."

In addition to Jack, local HIV specialist, William R. Short, MD, MPH, Assistant Professor of Medicine Division of Infectious Diseases Jefferson Medical College of Thomas Jefferson University will be available the weekend of the AIDS Walk to discuss the current landscape of HIV and AIDS treatment and research.

"There are many different treatment options available today. People with HIV should work with their doctor to find a treatment regimen that is right for them," said Dr. Short. "Through Living Positive By Design, we hope to educate the people living with HIV in Philadelphia about the importance of disease management."

Living Positive By Design was launched in 2008 in Miami/Fort Lauderdale, FL, at the 2008 United States Conference on AIDS (USCA). Since then, Jack has brought the campaign to Atlanta, GA at the Atlanta AIDS Walk; New York, NY at the Gay Men's Health Crisis' (GMHC) annual Fashion Forward fundraiser; San Francisco, CA at the Academy of Friends' annual Academy Awards Night Gala; Houston, TX at the AIDS Walk Houston; Chicago, IL at the AIDS Foundation of Chicago's Make a Statement: Design for the Cure event; and most recently to New Orleans, LA at the NO/AIDS Task Force's NO/AIDS Walk. He will continue to raise awareness about HIV and AIDS through events in additional cities in the coming months. For more information on Living Positive By Design, please visit:

Prevalence of HIV and AIDS

According to the Centers for Disease Control and Prevention (CDC), more than one million Americans are living with HIV and AIDS in the U.S. and approximately 55,000 new people become infected every year.(1), (2) At the end of 2008, there were 31,977 people living with AIDS in the state of Pennsylvania.(3) There are more than 20,000 people living with HIV and AIDS in Philadelphia(1) and roughly 1,400 new HIV diagnoses each year.(4)

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit

Forward-looking statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the risk factors and cautionary statements in Item 1A of Merck's Form 10-K for the year ended Dec. 31, 2008, and in any risk factors or cautionary statements contained in the Company's periodic reports on Form 10-Q or current reports on Form 8-K, which the Company incorporates by reference.


(1) Centers for Disease Control and Prevention. HIV/AIDS in the United States. (August 2008) Available at: Accessed April 1, 2009.

(2) Hall HI, Song R, Rhodes P. Estimation of HIV Incidence in the United States. Journal of the American Medical Association. 2008;520-529.

(3) Pennsylvania Department of Health. Surveillance Annual Summary (December 2008).

(4) Department of public health - Philadelphia (2007).

SOURCE Living Positive By Design

SOURCE Living Positive By Design
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. QI projects may -- or may not -- improve patient safety and outcomes
2. MU researchers to collaborate on $20 million project
3. Fry Construction Selected for High-Profile Medical Imaging Project
4. Jacobs Receives Contract for New Hospital Project in Belgium
5. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
6. Global Health Project targets reducing AIDS among Indias adolescents
7. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio
8. New Business Development of Multi-Hospital Project!
9. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
10. Meth Project Advertisements Selected for National Prevention Campaign
11. Pillow, PAs Great American Sleep Better(TM)Project Reports Results
Post Your Comments:
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating ... our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment ... day excited to rebuild lives and it’s an honor to have served all of ...
(Date:11/26/2015)... ... 26, 2015 , ... Pixel Film Studios brings Final Cut ... Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, with ... users limitless opportunities to stylize and create designs quickly and easily, all within ...
(Date:11/26/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact center ... reliability. , The new Q-Suite 6 platform is based on the latest Java Enterprise ... a specific piece of software for many key components of the suite. Much of ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015 --> ... online. The potential to save costs, improve treatment quality ... from fully exploited as yet. Here, particular emphasis is ... via mobile tablet or directly at the patients, bedside. ... ) -->      (Photo: ...
(Date:11/27/2015)... Research and Markets ( ) has announced the ... report to their offering. ... author the present scenario and growth prospects of the ... market size, the report considers revenue generated from the ... copper IUDs. The report forecasts the global intrauterine devices ...
(Date:11/26/2015)... November 26, 2015 Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Research . --> Clinical Cancer Research . ...
Breaking Medicine Technology: